A Long-Term Safety and Tolerability Study in Subjects With Mild to Moderate Alzheimer's Disease
A Phase 3 Extension, Multicenter, Double-Blind, Long-Term Safety and Tolerability Treatment Trial of Bapineuzumab (AAB-001, ELN115727) in Subjects With Alzheimer's Disease Who Participated in Study ELN115727-301 or Study ELN115727-302.
1 other identifier
interventional
896
3 countries
191
Brief Summary
The purpose of this study is to assess the long-term safety and tolerability of Bapineuzumab (AAB-001, ELN115727) in subjects with Alzheimer's disease who participated in study ELN115727-301 or study ELN115727-302.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for phase_3
Started Jul 2009
Typical duration for phase_3
191 active sites
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
July 1, 2009
CompletedFirst Submitted
Initial submission to the registry
July 7, 2009
CompletedFirst Posted
Study publicly available on registry
July 13, 2009
CompletedPrimary Completion
Last participant's last visit for primary outcome
September 1, 2012
CompletedStudy Completion
Last participant's last visit for all outcomes
September 1, 2012
CompletedDecember 20, 2013
November 1, 2013
3.2 years
July 7, 2009
November 26, 2013
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Clinically important changes in safety assessment results including vital signs, weight, clinical laboratory tests, electrocardiograms (ECGs), brain magnetic resonance imaging (MRI), physical and neurological examinations, and infusion site assessments.
Varies according to assessment: vital signs and adverse events on ongoing basis; MRI and ECG as required per protocol
Secondary Outcomes (1)
To evaluate the efficacy of long term treatment of IV administered bapineuzumab in subjects with AD.
The trial duration is expected to be approximately 4 years. The study will last up to the time of commercial launch of bapineuzumab, or termination of the clinical trials program, whichever comes first
Study Arms (2)
Bapineuzumab 0.5 mg/kg
ACTIVE COMPARATOR0.5 mg/kg
Bapineuzumab 1.0 mg/kg
ACTIVE COMPARATOR1.0 mg/kg
Interventions
0.5 mg/kg, administered via IV (in the vein) infusion every 13 weeks for 4 years. 1.0 mg/kg, administered via IV (in the vein) infusion every 13 weeks for 4 years.
Eligibility Criteria
You may qualify if:
- Diagnosis of probable AD
- Must have completed study 301 or study 302; and have completed Visit 15 (Week 78)
- Brain MRI scan to evaluate safety from Study 301 or 302 at Visit 14/Week 71
- Caregiver able to attend all clinic visits with patient
You may not qualify if:
- Any new medical contraindication or clinically significant abnormality on physical, neurological, laboratory, vital signs or ECG examination (eg, atrial fibrillation) that precludes continued or initiation of treatment with bapineuzumab or participation in the study
- Screening visit brain MRI scan (MRI from Study 301 or 302 Visit 14/Week 71) indicative of any significant abnormality not approved by the medical monitor prior to enrollment
- Current use of experimental medications for AD (other than bapineuzumab) and all other experimental medications, herbal preparations containing Ginko biloba, and anticoagulants (except the use of aspirin 325mg/day or less, Plavix, and Persantine but not for stroke)
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (191)
University of Alabama Hospital
Birmingham, Alabama, 35205, United States
Dedicated Clinical Research, Inc.
Goodyear, Arizona, 85395, United States
Banner Alzheimer's Institute
Phoenix, Arizona, 85006, United States
HOPE Research Institute, LLC
Phoenix, Arizona, 85050, United States
Banner Research Institute
Sun City, Arizona, 85351, United States
University of Arizona College of Medicine, Health Sciences Center
Tucson, Arizona, 85724, United States
Northwest NeuroSpecialists, PLLC
Tucson, Arizona, 85741, United States
Clinical Trials, Inc.
Little Rock, Arkansas, 72205, United States
East Bay Physicians Medical Group
Berkeley, California, 94705, United States
AVI Clinical Research
Carson, California, 90746, United States
ATP Clinical Research, Inc.
Costa Mesa, California, 92626, United States
Pharmacology Research Institute
Encino, California, 91316, United States
Margolin Brain Institute
Fresno, California, 93720, United States
Neurology Center of North Orange County
Fullerton, California, 92835, United States
Coordinated Clinical Research
La Jolla, California, 92037, United States
University of California San Diego
La Jolla, California, 92037, United States
Senior Clinical Trials, Inc.
Laguna Hills, California, 92653, United States
Collaborative NeuroScience Network, Inc.
Long Beach, California, 90806, United States
Pharmacology Research Institute
Los Alamitos, California, 90720, United States
UCLA Department of Neurology
Los Angeles, California, 90095, United States
Pharmacology Research Institute
Newport Beach, California, 92660, United States
Neurology Center
Oceanside, California, 92056, United States
University of California, Irvine Medical Center
Orange, California, 92868, United States
Neuro-Therapeutics, Inc.
Pasadena, California, 91105, United States
Sutter Neuroscience Medical Group
Sacramento, California, 95816, United States
University of California at Davis, Alzheimer's Disease Research Center
Sacramento, California, 95817, United States
Artemis Institute for Clinical Research
San Diego, California, 92123, United States
Sharp Mesa Vista Hospital
San Diego, California, 92123, United States
San Francisco Clinical Research Center
San Francisco, California, 94109, United States
University of California San Francisco
San Francisco, California, 94143, United States
Neurological Research Institute
Santa Monica, California, 90404, United States
Schuster Medical Research Institute
Sherman Oaks, California, 91403, United States
Diablo Clinical Research, Inc
Walnut Creek, California, 94596, United States
Alpine Clinical Research Center
Boulder, Colorado, 80304, United States
Mile High Research Center
Denver, Colorado, 80218, United States
Advanced Neurosciences Research, LLC
Fort Collins, Colorado, 80528, United States
Associated Neurologists, PC
Danbury, Connecticut, 06810, United States
Associated Neurologists of Southern Connecticut, P.C.
Fairfield, Connecticut, 06824, United States
Institute for Neurodegenerative Disorders
New Haven, Connecticut, 06510, United States
Yale University School of Medicine
New Haven, Connecticut, 06510, United States
Research Center for Clinical Studies, Inc.
Norwalk, Connecticut, 06851, United States
Chase Medical Research, LLC
Waterbury, Connecticut, 06708, United States
Christiana Care Neurology Specialists
Newark, Delaware, 19713, United States
Georgetown University Medical Center
Washington D.C., District of Columbia, 20057, United States
JEM Research, LLC
Atlantis, Florida, 33462, United States
Bradenton Research Center, Inc.
Bradenton, Florida, 34205, United States
Quantum Laboratories, Inc.
Deerfield Beach, Florida, 33064, United States
Brain Matters Research
Delray Beach, Florida, 33445, United States
Neurologic Consultants, PA
Fort Lauderdale, Florida, 33308, United States
Neuropsychiatric Research Center of Southwest Florida
Fort Myers, Florida, 33912, United States
Clinical Physiology Associates, Inc
Fort Myers, Florida, 33916, United States
Emerald Coast Mood and Memory, PA.
Fort Walton Beach, Florida, 32547, United States
MD Clinical
Hallandale, Florida, 33009, United States
Mayo Clinic College of Medicine
Jacksonville, Florida, 32224, United States
Neurology Associates
Maitland, Florida, 32751, United States
Melbourne Internal Medicine Associates
Melbourne, Florida, 32901, United States
Pharmax Research Clinic, LLC
Miami, Florida, 33126, United States
Miami Jewish Health Systems
Miami, Florida, 33137, United States
Allied Clinical Trials Inc.
Miami, Florida, 33156, United States
Miami Research Associates
Miami, Florida, 33173, United States
Renstar Medical Research
Ocala, Florida, 34471, United States
Compass Research, LLC
Orlando, Florida, 32806, United States
Palm Beach Neurological Center, Advanced Research Consultants, Inc.
Palm Beach Gardens, Florida, 33418, United States
Neurostudies, Inc.
Port Charlotte, Florida, 33952, United States
The Roskamp Institute, Inc
Sarasota, Florida, 34243, United States
Suncoast Neuroscience Associates, Inc.
St. Petersburg, Florida, 33713, United States
Axiom Clinical Research of Florida
Tampa, Florida, 33609, United States
Johnnie B. Byrd Sr. Alzheimer's Center and Research Institute
Tampa, Florida, 33613, United States
Stedman Clinical Trials, LLC
Tampa, Florida, 33613, United States
University of South Florida Suncoast Alzheimer's and Gerontology Center
Tampa, Florida, 33613, United States
Premiere Research Institute
West Palm Beach, Florida, 33407, United States
Emory University, School of Medicine
Atlanta, Georgia, 30322, United States
Multiple Sclerosis Center of Atlanta
Atlanta, Georgia, 30327, United States
NeuroTrials Research, Inc.
Atlanta, Georgia, 30342, United States
Medical Research and Health Education Foundation, Inc.
Columbus, Georgia, 31909, United States
Medical Research and Health Education Foundation, Inc
Columbus, Georgia, 31909, United States
DeKalb Neurology Associates, LLC
Decatur, Georgia, 30033, United States
Gwinnett Medical Center
Lawrenceville, Georgia, 30045, United States
University of Chicago Medical Center
Chicago, Illinois, 60637, United States
Alexian Brothers Neuroscience Institute
Elk Grove Village, Illinois, 60007, United States
Methodist Medical Center of Illinois
Peoria, Illinois, 61602, United States
Southern Illinois University School of Medicine
Springfield, Illinois, 62794, United States
Elkhart Clinic, LLC
Elkhart, Indiana, 46514, United States
Indiana University School of Medicine
Indianapolis, Indiana, 46202, United States
The University of Kansas Medical Center
Kansas City, Kansas, 66160, United States
MidAmerica Neuroscience Institute
Lenexa, Kansas, 66214, United States
Associates in Neurology, PSC
Lexington, Kentucky, 40513, United States
University of Kentucky
Lexington, Kentucky, 40536, United States
Four Rivers Clinical Research, Inc.
Paducah, Kentucky, 42003, United States
Lake Charles Clinical Trials
Lake Charles, Louisiana, 70629, United States
J. Gary Booker, MD, APMC
Shreveport, Louisiana, 71104, United States
Maine Medical Partners Neurology
Scarborough, Maine, 04074, United States
CBH Health, LLC
Rockville, Maryland, 20850, United States
Brigham and Women's Hospital, Dept. of Neurology
Boston, Massachusetts, 02115, United States
Boston University School of Medicine
Boston, Massachusetts, 02118, United States
ActivMed Practices and Research, Inc.
Haverhill, Massachusetts, 01830, United States
Neurocare, Inc.
Newton, Massachusetts, 02459, United States
Neuroscience Research of the Berkshires
Pittsfield, Massachusetts, 01201, United States
Donald S. Marks, MD, PC
Plymouth, Massachusetts, 02360, United States
Springfield Neurology Associates, LLC
Springfield, Massachusetts, 01104, United States
University of Michigan Medical Center
Ann Arbor, Michigan, 48105, United States
Henry Ford Hospital
Detroit, Michigan, 48202, United States
Michigan State University
East Lansing, Michigan, 48824, United States
Borgess Medical Center/Borgess Research Institute
Kalamazoo, Michigan, 49048, United States
Mayo Clinic
Rochester, Minnesota, 55905, United States
Hattiesburg Clinic
Hattiesburg, Mississippi, 39401, United States
Center for Pharmaceutical Research
Kansas City, Missouri, 64114, United States
Washington University School of Medicine
Saint Lous, Missouri, 63108, United States
Saint Louis University School of Medicine
St Louis, Missouri, 63104, United States
Deaconess Billings Clinical Research Center
Billings, Montana, 59101, United States
Advanced Neurology Specialists
Great Falls, Montana, 59405, United States
University of Nebraska Medical Center
Omaha, Nebraska, 68198, United States
Memory Enhancement Center of America, Inc.
Eatontown, New Jersey, 07724, United States
Alzheimer's Research Corporation
Paterson, New Jersey, 08759, United States
Global Medical Institutes, LLC
Princeton, New Jersey, 08540, United States
Shore Neurology, PA
Toms River, New Jersey, 08755, United States
Albuquerque Neuroscience, Inc.
Albuquerque, New Mexico, 87109, United States
Upstate Clinical Research, LLC
Albany, New York, 12205, United States
Neurological Associates of Albany, PC
Albany, New York, 12208, United States
Neuroscience Research Center at Albany Medical Center
Albany, New York, 12208, United States
Advanced BioBehavioral Sciences
Elmsford, New York, 10523, United States
Empire Neurology, PC
Latham, New York, 12110, United States
Neurological Care of Central New York
Liverpool, New York, 13088, United States
Parker Jewish Institute for Health Care and Rehabilitation
New Hyde Park, New York, 11040, United States
New York University School of Medicine/Psychiarty
New York, New York, 10016, United States
Columbia University Medical Center
New York, New York, 10032, United States
Nathan S. Kline Institute for Psychiatric Research
Orangeburg, New York, 10962, United States
University of Rochester Medical Center, Monroe Community Hospital
Rochester, New York, 14620, United States
Duke University Medical Center
Durham, North Carolina, 27710, United States
Clinical Trials of America, Inc
Hickory, North Carolina, 28601, United States
Raleigh Neurology Associates
Raleigh, North Carolina, 27607, United States
Neuro-Behavioral Clinical Research, Inc.
Canton, Ohio, 44718, United States
Ohio State University, Dept. of Neurology
Columbus, Ohio, 43210, United States
Neurology Specialists, Inc.
Dayton, Ohio, 45417, United States
Lynn Health Science Institute
Oklahoma City, Oklahoma, 73112, United States
Red River Medical Research Center, LLC
Oklahoma City, Oklahoma, 73112, United States
Providence Medical Group-Medford Neurology
Medford, Oregon, 97504, United States
Summit Research Group, LLC
Portland, Oregon, 97223, United States
Providence Health Service System, AD Center, Brain Institute
Portland, Oregon, 97225, United States
Oregon Health and Science University
Portland, Oregon, 97239, United States
Abington Neurological Associates, Ltd.
Abington, Pennsylvania, 19001, United States
Lehigh Valley Health Network
Allentown, Pennsylvania, 18103, United States
The Clinical Trial Center, LLC
Jenkintown, Pennsylvania, 19046, United States
Drexel University College of Medicine
Philadelphia, Pennsylvania, 19102, United States
Penn Memory Center
Philadelphia, Pennsylvania, 19104, United States
Jefferson Hospital for Neuroscience
Philadelphia, Pennsylvania, 19107, United States
Clinical Trials Research Services, LLC
Pittsburgh, Pennsylvania, 15206, United States
University of Pittsburgh
Pittsburgh, Pennsylvania, 15213, United States
Rhode Island Mood and Memory Research Institute
East Providence, Rhode Island, 02914, United States
Rhode Island Hospital
Providence, Rhode Island, 02903, United States
Butler Hospital
Providence, Rhode Island, 02906, United States
Medical University of South Carolina
North Charleston, South Carolina, 29406, United States
Avera Research Institute
Sioux Falls, South Dakota, 57105, United States
Neurology Clinic, P.C.
Cordova, Tennessee, 38018, United States
East Tennessee State University
Johnson City, Tennessee, 37614, United States
Volunteer Research Group
Knoxville, Tennessee, 37920, United States
Psychiatric Consultants, PC
Nashville, Tennessee, 37203, United States
Senior Adults Specialty Research (SASR)
Austin, Texas, 78757, United States
Texas Neurology, PA
Dallas, Texas, 75214, United States
University of Texas Southwestern Medical Center, Dept. of Neurology
Dallas, Texas, 75390, United States
InSite Clinical Research
DeSoto, Texas, 75115, United States
University of North Texas Health Science Center at Fort Worth
Fort Worth, Texas, 76106, United States
Baylor College of Medicine
Houston, Texas, 77030, United States
Innovative Clinical Trials
San Antonio, Texas, 78229, United States
Integra Clinical Research, LLC
San Antonio, Texas, 78231, United States
Wasatch Clinical Research
Salt Lake City, Utah, 84107, United States
University of Utah, Dept. of Neurology
Salt Lake City, Utah, 84108, United States
The Memory Clinic
Bennington, Vermont, 05201, United States
Fletcher Allen Health Care
Burlington, Vermont, 05401, United States
Innovative Clinical Research Center
Alexandria, Virginia, 22304, United States
University of Virginia
Charlottesville, Virginia, 22903, United States
Alliance Research Group, LLC
Richmond, Virginia, 23230, United States
University of Washington Veterans Affairs
Seattle, Washington, 98108, United States
Pacific Medical Centers
Seattle, Washington, 98144, United States
Medical College of Wisconsin, Froedtert Memorial Lutheran Hospital
Milwaukee, Wisconsin, 53226, United States
Independent Psychiatric Consultants
Waukesha, Wisconsin, 53188, United States
Landeskrankenhaus- Universitätsklinikum Graz
Graz, Styria, 8036, Austria
University of Calgary, Foothills Medical Centre
Calgary, Alberta, T2N 4Z6, Canada
Medical Arts Health Research Group
Kamloops, British Columbia, V2C 1K7, Canada
Medical Arts Health Research Group
Kelowna, British Columbia, V1Y 3G8, Canada
Queens University Memorial Clinics
Kingston, Ontario, K7L 5G2, Canada
Parkwood Hospital
London, Ontario, N6C 5J1, Canada
Bruyere Continuing Care
Ottawa, Ontario, K1N 5C8, Canada
Neurology Research Inc
Toronto, Ontario, M3B 2S7, Canada
Toronto Centre for Memory and Aging
Toronto, Ontario, M6M 3Z5, Canada
Ontario Shores Centre for Mental Health Sciences
Whitby, Ontario, L1N 5S9, Canada
Neuro Rive-Sud Memory Clinic
Greenfield Park, Quebec, J4V 2J2, Canada
Hôpital Maisonneuve-Rosemont
Montreal, Quebec, H1T 2M4, Canada
Sir Mortimer B. Davis, Jewish General Hospital
Montreal, Quebec, H3T 1E2, Canada
Diex Research Sherbrooke Inc.
Sherbrooke, Quebec, J1H 1Z1, Canada
Douglas Mental Health University Institute
Verdun, Quebec, H4H 1R3, Canada
MeSH Terms
Conditions
Interventions
Condition Hierarchy (Ancestors)
Study Design
- Study Type
- interventional
- Phase
- phase 3
- Allocation
- RANDOMIZED
- Masking
- QUADRUPLE
- Who Masked
- PARTICIPANT, CARE PROVIDER, INVESTIGATOR, OUTCOMES ASSESSOR
- Purpose
- TREATMENT
- Intervention Model
- PARALLEL
- Sponsor Type
- INDUSTRY
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
July 7, 2009
First Posted
July 13, 2009
Study Start
July 1, 2009
Primary Completion
September 1, 2012
Study Completion
September 1, 2012
Last Updated
December 20, 2013
Record last verified: 2013-11